Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Handling uncertainty in cost-effectiveness models.

A H Briggs1

  • 1Health Economics Research Centre, University of Oxford, England. andrew.briggs@ihs.ox.ac.uk

Pharmacoeconomics
|September 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Buffalo Medical Library Association: Meeting of Directors.

Buffalo medical and surgical journal·2023
Same author

The Buffalo Medical Library Association: First Meeting, December 15th, 1882.

Buffalo medical and surgical journal·2023
Same author

Meeting of the Board of Officers and Directors.

Buffalo medical and surgical journal·2023
Same author

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.

BJOG : an international journal of obstetrics and gynaecology·2022
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

This review explores managing uncertainty in economic modeling for cost-effectiveness analysis. It details methods like Bayesian statistics and Monte Carlo simulation to improve result reliability.

Area of Science:

  • Health Economics
  • Decision Analysis
  • Statistical Modeling

Background:

  • Economic evaluations frequently utilize modeling to synthesize data from diverse sources.
  • Modeling is crucial even when economic evaluations accompany clinical trials.

Purpose of the Study:

  • To review the methodologies for handling uncertainty in cost-effectiveness results derived from decision-analytic modeling.
  • To enhance the comparability and reliability of economic evaluation outcomes.

Main Methods:

  • Defining a 'reference case' with agreed-upon methods for comparability.
  • Specifying patient characteristics with experimental study rigor.
  • Estimating data requirements using Bayesian statistics and prior distributions for model parameters.
  • Employing Monte Carlo simulation for probabilistic analyses of cost-effectiveness.

Related Experiment Videos

Main Results:

  • Probabilistic analyses, utilizing Monte Carlo simulation, generate distributions of cost-effectiveness.
  • Parameter uncertainty is addressed through sampling from prior distributions.
  • Modelling uncertainty introduces an additional layer of uncertainty to analysis results.

Conclusions:

  • Standardized methods and Bayesian approaches are key to managing uncertainty in economic modeling.
  • Accurate specification of patient characteristics and parameter distributions improves model validity.
  • Acknowledging both parameter and modeling uncertainty is essential for robust cost-effectiveness conclusions.